Global Nebulizer Market 2017-2021
Nebulizers are medical devices used to administer drugs. The drugs are converted into a form of aerosol and delivered directly into the lungs. Nebulizers use compressed air or oxygen or ultrasonic power to break drug solutions into aerosol droplets, which can be inhaled using the mouthpiece of the device. They are commonly used for the treatment of respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable and are widely used in healthcare settings.
Technavio’s analysts forecast the global nebulizer market to grow at a CAGR of 6.15% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global nebulizer market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Nebulizer Market 2017-2021
Technavio recognizes the following companies as the key players in the global nebulizer market: Allied Healthcare, BD, Omron Healthcare, PARI Medical, and Koninklijke Philips.
Other Prominent Vendors in the market are: Aerogen, Agilent Technologies, AirSsential, Briggs Healthcare, HAAG-STREIT GROUP, DeVilbiss Healthcare, GF HEALTH PRODUCTS, Medtronic, and Salter Labs.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing demand for home-care services. The healthcare sector is witnessing a growing trend of patients' preference for home-care services over hospitals and clinics due to the desire to receive medical treatment in the comfort of their homes. The demand for home-care services has further increased due to the medical needs of the growing geriatric and terminally ill population.”
According to the report, one driver in the market is rising prevalence of respiratory disorders. Respiratory disorders such as COPD, asthma, bronchitis, emphysema, cystic fibrosis, pneumonia, and lung cancer are increasing in several developed and developing nations. Asthma is considered a major cause of disability. According to a CDC statistic, asthma prevalence has increased from 20.3 million in 2001 to approximately 25.7 million in 2010, of which 7.0 million people are below the age of 18 years in the US.
Further, the report states that one challenge in the market is availability of nebulizer substitutes. Nebulizers convert medicines in the form of liquid or suspension into aerosols that can be easily inhaled into the lungs. It is used to treat chronic respiratory diseases such as asthma, emphysema, COPD, bronchitis, and pneumonia. Nebulizers provide an effective way to administer the medication. However, it is not always feasible to carry these devices everywhere. Even though portable nebulizers are available, they are often battery-operated, and hence, have a limited run time.
Allied Healthcare, BD, Omron Healthcare, PARI Medical, and Koninklijke Philips, Aerogen, Agilent Technologies, AirSsential, Briggs Healthcare, HAAG-STREIT GROUP, DeVilbiss Healthcare, GF HEALTH PRODUCTS, Medtronic, and Salter Labs.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook